期刊文献+
共找到10篇文章
< 1 >
每页显示 20 50 100
Catheter ablation for atrial fibrillation in heart failure:untying the Gordian knot 被引量:1
1
作者 Saad Javed Ioanna Koniari +3 位作者 David Fox Chris Skene Gregory YH Lip Dhiraj Gupta 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2021年第4期297-306,共10页
Atrial fibrillation(AF) and heart failure(HF) are complex clinical entities that occur concomitantly in a significant population of patients, and their prevalence is rising in epidemic proportions. Traditionally, both... Atrial fibrillation(AF) and heart failure(HF) are complex clinical entities that occur concomitantly in a significant population of patients, and their prevalence is rising in epidemic proportions. Traditionally, both rate and rhythm control strategies have been regarded as equivalent in the management of dysrhythmia in this AF-HF cohort with escalation of treatment largely guided by symptoms. Both disorders are involved in an elaborate pathophysiological interplay with shared cardiovascular risk factors that contribute to the development and sustenance of both AF and HF. Recent studies and continued development of evidence to support catheter ablation for AF has brought into question the traditional belief in equivalence between rate and rhythm control. Indeed, recent trials, in particular the CASTLE-AF(Catheter Ablation versus Standard Conventional Therapy in Patients with Left Ventricular Dysfunction and Atrial Fibrillation) study, suggest that catheter ablation for AF improves survival and rates of hospitalisation in patients with concomitant HF and AF, threatening a paradigm shift in the management of this patient cohort. The evident mortality benefit from clinical trials suggests that catheter ablation for AF should be considered as a therapeutic intervention in all suitable patients with the AF-HF syndrome as these patients may derive the greatest benefit from restoration of sinus rhythm. Further research is needed to refine the evidence base, especially to determine which subgroup of HF patients benefit most from catheter ablation and what is the optimal timing. 展开更多
关键词 Catheter ablation for atrial fibrillation in heart failure:untying the Gordian knot
下载PDF
Frailty and Anticoagulant Therapy in Patients Aged 65 Years or Older with Atrial Fibrillation
2
作者 Jiapeng Liu Xin Du +8 位作者 Mengmeng Li Zhaoxu Jia Shangxin Lu Sanshuai Chang Ribo Tang Rong Bai Jianzeng Dong Gregory Y.H.Lip Changsheng Ma 《Cardiovascular Innovations and Applications》 2020年第1期153-161,共9页
Background:Elderly adults with atrial fi brillation(AF)are at increased risk of frailty and thromboembolic complications.However,studies on the prevalence of frailty in AF patients and data on the relationship between... Background:Elderly adults with atrial fi brillation(AF)are at increased risk of frailty and thromboembolic complications.However,studies on the prevalence of frailty in AF patients and data on the relationship between frailty and the use of anticoagulants are limited.Methods:We conducted a cross-sectional study involving 500 participants.Patients aged 65 years or older were consecutively selected from the Chinese Atrial Fibrillation Registry study.The patient’s frailty status was assessed with use of the Canadian Study of Health and Aging Clinical Frailty Scale.We assessed the prevalence of and factors associated with frailty,and how frailty affects anticoagulant therapy.Results:In 500 elderly adults with AF(age 75.2±6.7 years;51.6%female),201 patients(40.2%)were frail.The prevalence of frailty was higher in females(P=0.002)and increased with age and CHA 2 DS 2-VASc score(P for trend less than 0.001 for both).The factors associated with frailty were a history of heart failure(odds ratio[OR]2.40,95%confi dence interval[CI]1.39–4.14),female sex(OR 2.09,95%CI 1.27–3.43),and advanced age(OR 1.13,95%CI 1.09–1.17).Frail patients were signifi cantly less likely to have ever been prescribed anticoagulants compared with nonfrail patients(81.7 vs.54.9%,P<0.001).Conclusions:Frailty is prevalent in elderly adults with AF,especially in females,those of advanced age,and those with heart failure.Frailty status has a signifi cant impact on prescription of anticoagulants for high-risk AF patients. 展开更多
关键词 ATRIAL fi brillation FRAILTY ANTICOAGULANT elderly ADULTS
下载PDF
Literature Review for the Management of Isolated Internal Mammary Artery Injury and a Case Managed by Mini-Thoracotomy
3
作者 Mohammad Miah Mauin Uddin +3 位作者 Jalal Bin Saeid Syed Al Nahian Anwar Karim Ahmed Ashoub 《World Journal of Cardiovascular Surgery》 2019年第8期83-88,共6页
Penetrating injuries to anterior chest may result in life-threatening complications such as massive haemothorax,?as a result of injury to the internal mammary artery.?Isolated internal mammary injury is a very rare ca... Penetrating injuries to anterior chest may result in life-threatening complications such as massive haemothorax,?as a result of injury to the internal mammary artery.?Isolated internal mammary injury is a very rare cause of massive haemothorax and associated with high mortality.?We are presenting this?32-year-old gentleman who sustained a thoracic stab wound and had an emergency right anterior mini-thoracotomy?by extending the stab wound rather than standard thoracotomy or sternotomy.?This case of isolated penetrating IMA injury managed with mini-thoracotomy is the only documented case so far. We are publishing this case report with patient’s both written and informed consent and institutional approval.?This potentially life-threating injury can be managed by mini-thoracotomy with enhanced recovery;however, it is case specific and needs proper judgement. 展开更多
关键词 Internal MAMMARY ARTERY (IMA) Mini-Thoracotomy Massive HAEMOTHORAX External Cardiac TAMPONADE
下载PDF
Patient with Churg Strauss Syndrome and Myocarditis Treated with Cyclophosphamide
4
作者 Liam Mullen Janice Harper Sukumaran Binukrishnan 《Open Journal of Nephrology》 2012年第3期35-37,共3页
Cardiac involvement in Churg Strauss Syndrome is common and a poor prognostic indicator. Myocarditis in Churg Strauss Syndrome can present in different ways. It has been shown that basic cardiac investigations includi... Cardiac involvement in Churg Strauss Syndrome is common and a poor prognostic indicator. Myocarditis in Churg Strauss Syndrome can present in different ways. It has been shown that basic cardiac investigations including echocardiography can be normal even in symptomatic patients. More recently cardiac magnetic resonance imaging (MRI) has been shown to be more sensitive in its diagnosis. Our case report describes a 45 year old male who presented with palpitations and breathlessness. Echocardiography was normal but cardiac MRI demonstrated abnormalities consistent with Myocarditis. He was treated with Cyclophosphamide and follow up MRI imaging demonstrated complete resolution of these abnormalities which was accompanied by resolution of symptoms. This case therefore supports the use of cardiac MRI in Churg Strauss Syndrome as a sensitive diagnostic tool in and as a means of monitoring response to therapy. It also supports the therapeutic effectiveness of Cyclophosphamide therapy in Churg Strauss related Myocarditis, something that has yet to be assessed on a large scale. 展开更多
关键词 CARDIAC MRI CYCLOPHOSPHAMIDE MYOCARDITIS Churg Strauss SYNDROME
下载PDF
Midventricular Takotsubo syndrome 被引量:1
5
作者 Konstantinos C Theodoropoulos Ioannis Felekos +2 位作者 Chris Abell Nicholas D Palmer Turab Ali 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2020年第5期303-304,共2页
A 78-year-old woman with a background of type 2 diabetes mellitus,hyperlipidaemia and hypertension experienced sudden onset severe chest pain while in the emergency department,after a stressful emotional event.The pai... A 78-year-old woman with a background of type 2 diabetes mellitus,hyperlipidaemia and hypertension experienced sudden onset severe chest pain while in the emergency department,after a stressful emotional event.The pain lasted for 20-30 min and the patient developed widespread T-wave inversion on 12-lead ECG. 展开更多
关键词 Left ventriculography Midventricular Takotsubo syndrome
下载PDF
A quantification of the treadmill 6-min walk test using the My Wellness Key^(TM) accelerometer
6
作者 S.Andy Sparks Nathan P.Hilton 《Journal of Sport and Health Science》 SCIE 2015年第2期188-194,共7页
Background: Accelerometers have been suggested to provide additional information during the 6-min walk test which may be useful in evaluating changes in functional exercise capacity. The aim of the study was to ident... Background: Accelerometers have been suggested to provide additional information during the 6-min walk test which may be useful in evaluating changes in functional exercise capacity. The aim of the study was to identify whether the additional information measured by the My Wellness Key^TM(MWK) accelerometer during a treadmill 6-min walk test(t-6MWT) was related to currently used outcome measures.Methods: Fifteen participants(9 males, 6 females) performed a self-paced t-6MWT. Respiratory gas analysis and walking distance were measured whilst wearing the MWK.Results: A significant correlation was established between activity counts and 6-min walk distance(6MWD)(r=-0.847, p 〈 0.001) yet not 6-min walk work(6MWW)(r=-0.337, p=0.220). Energy expenditure estimated by the MWK was strongly correlated to 6MWW(r=0.938, p 〈 0.001)but not 6MWD(r=0.477, p=0.072). The MWK significantly underestimated energy expenditure(36.73, CI=33.9-39.7 kcal) compared to gas analysis(54.35, CI=46.2-61.4 kcal) demonstrating poor agreement between the two analyses(Bias=-17.61 kcal, Limits of agreement=-37.4,t2.2 kcal). Measurement of time spent undertaking light, moderate, and vigorous physical activity was not significantly different( p 〉 0.05)between the MWK and gas analysis.Conclusion: Estimated energy expenditure provided by the MWK was strongly correlated to 6MWW; however, MWK underestimated energy expenditure as measured by gas analysis. The MWK may provide outcome data that supplement those currently provided by the 6MWD for functional capacity assessment during the t-6MWT. 展开更多
关键词 6MWD ACCELEROMETRY Physical activity assessment Physical fitness Treadmill 6MWT
下载PDF
All CABG Patients Who Have No Contraindications: Do They Get Perioperative Beta Blockers?
7
作者 Mohammad Miah Mauin Uddin +3 位作者 Syed Al Nahian Khalid Zahir Mostafa Mehanna Ahmed Ashoub 《International Journal of Clinical Medicine》 2019年第9期421-427,共7页
New-onset postoperative atrial fibrillation (POAF) following Coronary artery bypass graft (CABG) surgery has been described in up to 15% to 40% of patients in the initial postoperative period. POAF is related with hig... New-onset postoperative atrial fibrillation (POAF) following Coronary artery bypass graft (CABG) surgery has been described in up to 15% to 40% of patients in the initial postoperative period. POAF is related with higher mortality, increased hospital resource utilization, postoperative extra ITU hours and hospital days, consequently increasing hospital-related budgets. Beta blocker administration decreases the rate of POAF from 30% - 40% to 12% - 16% after CABG. According to the EACTS (European Association of Cardiothoracic Surgery) guideline December 2006, &beta;-Blockers should routinely be used as the first choice for the prophylaxis of atrial fibrillation (AF) in all patients undergoing cardiac surgery, if not contraindicated (IB). To compare the contemporary practice with the recommended standard retrospective data of consecutive 400 patients treated with isolated CABG between July 2015 and June 2017 were collected. Those patients who received &beta;-blockers on the day of surgery or the following morning (Continued and Restarted on 1st POD) met the standard guidelines. Thus, according to the data (12% + 20%) 32% of the patients met the standard. To compare the rate of Postoperative Atrial fibrillation, we divided the patients into two groups. Group A, who followed the guideline (128 patients) and Group B, who resumed &beta;-Blockers 48 hours onwards (272 Patients). In group A, only 8 patients developed postoperative AF whereas in group B 88 patients developed postoperative AF which is also statistically significant (P &beta;-blockers use at perioperative period. 展开更多
关键词 CABG-Coronary Artery Bypass Graft Β-BLOCKERS AF-Atrial FIBRILLATION POAF-Postoperative ATRIAL FIBRILLATION
下载PDF
Right Ventricular Failure Following Acute Type A Aortic Dissection: An Alternative Strategy
8
作者 Ruchir P. Mashar Rashmi P. Birla Paul D. Waterworth 《World Journal of Cardiovascular Surgery》 2019年第3期35-39,共5页
Coronary malperfusion is a complication of aortic dissection, and can lead to ventricular failure. We report 2 cases of right ventricular (RV) failure, following aortic dissection, successfully bridged to recovery usi... Coronary malperfusion is a complication of aortic dissection, and can lead to ventricular failure. We report 2 cases of right ventricular (RV) failure, following aortic dissection, successfully bridged to recovery using right ventricular assist devices (RVADs). The first was a 54 year-old man, who had difficulty weaning from bypass due to a stunned RV following aortic root replacement. The second was a 34 year-old woman, who after replacement of the ascending aorta, suffered episodes of ventricular fibrillation (VF), and RV failure. Both had an RVAD implanted, allowing eventual recovery. We recommend more widespread use of VADs in such cases. 展开更多
关键词 RIGHT VENTRICULAR Failure Assist Devices ACUTE Type A AORTIC DISSECTION
下载PDF
ABC-AF-Stroke score predicts thromboembolism in nonanticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry
9
作者 Yufeng Wang Chao Jiang +9 位作者 Liu He Xin Du Xueyuan Guo Ribo Tang Caihua Sang Deyong Long Jianzeng Dong Ziad Hijazi Gregory YHLip Changsheng Ma 《Chinese Medical Journal》 SCIE CAS CSCD 2023年第20期2451-2458,共8页
Background:The age,biomarkers,and clinical history(ABC)-atrial fibrillation(AF)-Stroke score have been proposed to refine stroke risk stratification,beyond what clinical risk scores such as the CHA2DS2-VASc score can ... Background:The age,biomarkers,and clinical history(ABC)-atrial fibrillation(AF)-Stroke score have been proposed to refine stroke risk stratification,beyond what clinical risk scores such as the CHA2DS2-VASc score can offer.This study aimed to identify risk factors associated with thromboembolism and evaluate the performance of the ABC-AF-Stroke score in predicting thromboembolism in non-anticoagulated AF patients following successful ablations.Methods:A total of 2692 patients who underwent successful ablations with discontinued anticoagulation after a 3-month blanking period in the Chinese Atrial Fibrillation Registry(CAFR)between 2013 and 2019 were included.Cox regression analysis was conducted to present the association of risk factors with thromboembolism risk.The ABC-AF-Stroke score was evaluated in terms of discrimination,including concordance index(C-index),net reclassification improvement(NRI)and integrated discrimination improvement(IDI),clinical utilization by decision curve analysis(DCA),and calibration by comparing the predicted risk with the observed annualized event rate.Results:After a median follow-up of 3.5 years,64 patients experienced thromboembolism events.Age,prior history of stroke/transient ischemic attack(TIA),high-sensitivity cardiac troponin T(cTnT-hs),and N-terminal pro-B-type natriuretic peptide(NT-proBNP)were independently associated with thromboembolism risk.The ABC-AF-Stroke score performed statistically significantly better than the CHA2DS2-VASc score in terms of C-index(0.67,95%confidence interval[CI]:0.59-0.74 vs.0.60,95%CI:0.52-0.67,P=0.030)and reclassification capacity.The DCA implied that the ABC-AF-Stroke score could identify more thromboembolism events without increasing the false positive rate compared to the CHA2DS2-VASc score.The calibration curve showed that the ABC-AF-Stroke score was well calibrated in this population.Conclusions:In this real-world study enrolling non-anticoagulated AF patients following successful ablations,age,prior history of stroke/TIA,level of NT-proBNP,and cTnT-hs were independently associated with an increased risk of thromboembolism.The ABC-AF-Stroke score was well-calibrated and statistically significantly outperformed the CHA2DS2-VASc score in predicting thromboembolism risk. 展开更多
关键词 Atrial fibrillation ABC-AF-Stroke score CHAS2DS2-VASc THROMBOEMBOLISM Catheter ablation
原文传递
囊性纤维化的诊断和治疗:NICE指南摘要
10
作者 Gemma Villanueva Gemma Marceniuk +4 位作者 M Stephen Murphy Martin Walshaw Rami Cosulich 齐进春(译) 董强(校) 《英国医学杂志中文版》 2022年第7期406-411,共6页
囊性纤维化是一种影响寿命的常染色体隐性遗传疾病,在英国出生的婴儿中,该病的发病率为1/2500。囊性纤维化是一种多系统疾病,它的发病原因为细胞膜表面的囊性纤维化跨膜传导调节蛋白突变,进而影响体内所有产生黏液的器官,包括肺、胰腺... 囊性纤维化是一种影响寿命的常染色体隐性遗传疾病,在英国出生的婴儿中,该病的发病率为1/2500。囊性纤维化是一种多系统疾病,它的发病原因为细胞膜表面的囊性纤维化跨膜传导调节蛋白突变,进而影响体内所有产生黏液的器官,包括肺、胰腺、肝和肠。在英国,该病通常通过新生儿筛查即可做出诊断,确诊的平均年龄为2月龄,也有一些患者在更大年龄甚至在成年后才被发现1。 展开更多
关键词 囊性纤维化 新生儿筛查 多系统疾病 常染色体隐性遗传疾病 发病原因
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部